Danaher Co. (NYSE:DHR) Stock Holdings Reduced by TCG Advisory Services LLC

TCG Advisory Services LLC lowered its position in Danaher Co. (NYSE:DHRGet Rating) by 26.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 990 shares of the conglomerate’s stock after selling 365 shares during the quarter. TCG Advisory Services LLC’s holdings in Danaher were worth $251,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Advisor OS LLC grew its stake in Danaher by 0.6% in the second quarter. Advisor OS LLC now owns 6,253 shares of the conglomerate’s stock valued at $1,585,000 after purchasing an additional 37 shares in the last quarter. Strengthening Families & Communities LLC grew its stake in Danaher by 3.2% in the second quarter. Strengthening Families & Communities LLC now owns 1,248 shares of the conglomerate’s stock valued at $364,000 after purchasing an additional 39 shares in the last quarter. Journey Advisory Group LLC grew its stake in Danaher by 2.5% in the second quarter. Journey Advisory Group LLC now owns 1,648 shares of the conglomerate’s stock valued at $475,000 after purchasing an additional 40 shares in the last quarter. Rosenbaum Jay D. grew its stake in Danaher by 1.1% in the second quarter. Rosenbaum Jay D. now owns 3,564 shares of the conglomerate’s stock valued at $904,000 after purchasing an additional 40 shares in the last quarter. Finally, Howe & Rusling Inc. grew its stake in Danaher by 48.8% in the first quarter. Howe & Rusling Inc. now owns 128 shares of the conglomerate’s stock valued at $38,000 after purchasing an additional 42 shares in the last quarter. Hedge funds and other institutional investors own 77.27% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 1,884 shares of the company’s stock in a transaction that occurred on Tuesday, November 15th. The stock was sold at an average price of $271.61, for a total value of $511,713.24. Following the completion of the transaction, the senior vice president now owns 2,588 shares of the company’s stock, valued at approximately $702,926.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, SVP Georgeann Couchara sold 1,884 shares of the stock in a transaction that occurred on Tuesday, November 15th. The stock was sold at an average price of $271.61, for a total value of $511,713.24. Following the completion of the transaction, the senior vice president now directly owns 2,588 shares of the company’s stock, valued at approximately $702,926.68. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Alan G. Spoon sold 500 shares of the stock in a transaction that occurred on Tuesday, October 25th. The stock was sold at an average price of $252.93, for a total value of $126,465.00. Following the completion of the transaction, the director now directly owns 107,135 shares of the company’s stock, valued at $27,097,655.55. The disclosure for this sale can be found here. Insiders sold a total of 29,530 shares of company stock valued at $8,015,916 in the last quarter. Corporate insiders own 11.20% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR traded up $1.31 during trading hours on Thursday, hitting $263.35. 1,549,554 shares of the company’s stock were exchanged, compared to its average volume of 2,941,794. Danaher Co. has a 1-year low of $233.71 and a 1-year high of $331.68. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.78 and a quick ratio of 1.38. The stock has a market capitalization of $191.71 billion, a price-to-earnings ratio of 29.10, a PEG ratio of 2.07 and a beta of 0.82. The company’s 50-day moving average price is $261.17 and its 200-day moving average price is $264.64.

Danaher (NYSE:DHRGet Rating) last posted its quarterly earnings data on Thursday, October 20th. The conglomerate reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.32. The business had revenue of $7.66 billion during the quarter, compared to analysts’ expectations of $7.17 billion. Danaher had a return on equity of 18.33% and a net margin of 21.65%. The firm’s revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.39 EPS. On average, sell-side analysts expect that Danaher Co. will post 10.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 28th. Shareholders of record on Friday, September 30th were issued a $0.25 dividend. The ex-dividend date was Thursday, September 29th. This represents a $1.00 annualized dividend and a yield of 0.38%. Danaher’s dividend payout ratio (DPR) is 11.05%.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Royal Bank of Canada lowered their target price on Danaher from $318.00 to $302.00 and set an “outperform” rating on the stock in a research note on Friday, October 21st. Robert W. Baird decreased their price target on Danaher from $325.00 to $315.00 and set an “outperform” rating for the company in a research note on Friday, October 21st. JPMorgan Chase & Co. decreased their price target on Danaher from $350.00 to $315.00 and set an “overweight” rating for the company in a research note on Friday, October 21st. Barclays decreased their price target on Danaher from $310.00 to $305.00 and set an “overweight” rating for the company in a research note on Thursday, October 6th. Finally, Sanford C. Bernstein initiated coverage on Danaher in a research note on Tuesday, August 16th. They set an “outperform” rating and a $340.00 price target for the company. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $312.50.

Danaher Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.